天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Shanghai Yifei Biotechnology Co. , Ltd.??? ?? ??? ?????.

?? ?:Shanghai Yifei Biotechnology Co. , Ltd.
??:021-65675885
???:customer_service@efebio.com
??:China
URL: http://www.efebio.com
? ?? ?:11974
94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

?? ????

TL12-1862250025-88-6C44H51ClN10O9S
IR820-PTX2250419-19-1
Pirepemat fumarate2251806-70-7C15H17F2NO5
Aβ/tau aggregation-IN-12252162-81-3C25H21IN2O
RAS GTPase inhibitor 12252242-32-1C27H28ClF4N5O2
Sabatolimab2252262-24-9
Feladilimab2252518-85-5
BCL6-IN-32253878-44-1C24H31ClF2N6O2
bisSP12253947-15-6C12H23N9O2
(2′S)-4′-O-β-D-apiofuranosyl-(1→6)-O-β-D-glucopyranosylvisamminol2254096-97-2C26H34O14
Upifitamab2254118-43-7
NLRP3-IN-172254432-75-0
AMPC2254434-33-6C25H16FN3O3
FenitrooxoneFENITROTHION-O-????2255-17-6C9H12NO6P
Bafrekalant2256770-44-0C29H31ClN6O2
Isothiuronium22584-04-9C12H25IN2S
Bexmarilimab2259301-27-2
Rosopatamab2260767-49-3
OSMI-32260791-13-5C32H35N3O9S2
TH-Z1452260887-57-6C16H28O7P2
DNDI-61482243909-59-1C16H14BN5O3
2-Quinoxalinecarboxylic acid-d42244217-89-6C9H6N2O2
3-Methyl-2-quinoxalinecarboxylic Acid-d42244217-93-2C10H4D4N2O2
Amine-PEG3-Lys(PEG3-N3)-PEG3-N32244602-35-3C30H58N10O12
Cudarolimab2244739-29-3
Idactamab2245205-37-0
GSK-2807 free base2245255-65-4C19H32N8O5
ARX-17962245880-46-8C14H23N3O8S
Janelia Fluor 549 TFA2245946-45-4C29H23F3N2O7
Tubulin inhibitor 352247047-77-2
Adebrelimab2247114-85-6
BY272247236-59-3C22H21ClN6
AW682247236-61-7
ITF37562247608-27-9C13H11N5O2S
AHR antagonist 52247953-39-3C25H25ClFN7
STAT3-IN-132248552-86-3C21H20N6O3S
Ziltivekimab2226654-05-1
Itepekimab2226742-52-3
Tilvestamab2226775-26-2
UNC52932226789-82-6C30H42N6O2
Favezelimab2231068-83-8
BI-14082231075-94-6C22H23FN6
ALDH1A1-IN-22231081-18-6C25H23ClN4O3S
NCT-5062231098-99-8C25H23FN4O3S
Vibostolimab (anti-TIGIT)2231305-30-7
BMT-090605 hydrochloride2231664-45-0C21H25ClN4O2
AZ22231760-33-9C20H23N3O2S
SHR16532231770-73-1C21H21ClFN5O2
EMT inhibitor-22232228-60-1C24H26N2O8
PDDC inhibitor2232878-43-0C27H29N5O4
AP-C52234272-10-5C16H13N5
Atagabalin HCl223445-67-8C10H20ClNO2
(Iso)-Atagabalin HCl223445-68-9
HDAC6 degrader 9c2235382-05-3C37H45N9O10
Nampt activator-22237268-90-3C17H15ClN4O3S
DMA-135 hydrochloride2237925-62-9C16H18ClN7O
22393-62-0_peak 2(Z)-1-???-1,2-???-2-(p-????)??22393-63-1C22H19Br
Hu7691 free base2241232-43-7C22H21F3N4O
LY33726892241514-56-5C16H22FN5O3S
BTK inhibitor 102241732-30-7C25H23N5O3
MMP-9-IN-62241964-36-1
Tesnatilimab2242758-08-1
Vixarelimab2243320-83-2
GSK-3 inhibitor 32227279-84-5C23H15FN6O
CXCR7 modulator 22227426-37-9C29H42N6O3
Mezagitamab2227490-52-8
HPK1-IN-192227609-33-6C27H32N7O2P
Ragaglitazar222834-30-2C25H25NO5
HPK1-IN-262229042-24-2C19H21N5OS
ZL04542229042-77-5C18H22N4O3S
Glofitamab2229047-91-8
Avizakimab2229685-51-0
Mirzotamab2229859-11-2
Revdofilimab2230138-89-1
Lorpucitinib2230282-02-5C22H28N6O2
KDM4-IN-42230475-63-3C16H23NO
JNJ-653553942230598-99-7C19H26N4OS
Nrf2 activator-12230697-41-1C30H34N4O6S
EHMT2-IN-12230849-55-3C18H23N7O
Serplulimab2231029-82-4
Ar-V7-IN-12230880-25-6C10H10Br2N4OS
RORγt inverse agonist 232230779-18-5C26H33NO5S
Alogabat2230009-48-8C21H23N5O4
GSK-3 inhibitor 42227279-83-4C22H15F2N5O
CFTR corrector 62226970-01-8C22H13F4N9
AUTAC12241669-09-8
Triflubazam??????22365-40-8C17H13F3N2O2
ERα degrader-22235396-63-9C29H27F3N2O2
cpd.5 of 2234271-86-22234284-82-1C12H11NO3
Opevesostat2231294-96-3C21H26N2O5S
Pirmitegravir2245231-10-9C27H31ClN4O3
PARP1/2/TNKS1/2-IN-12243453-32-7
4-PQBH2243355-51-1C22H17N5O
S21572262488-39-9C23H28ClF2N3O2
USP15-IN-12260826-16-0C22H23N3O3
SY-LB-572253719-35-4C16H13N3O
Oditrasertib2252271-93-3C14H15F2N3O2
MEISi-22250156-71-7C18H14N2O3
Pimicotinib2253123-16-7
94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2019 ? ChemicalBook. All rights reserved